HC Wainwright & Co.:重申Emergent BioSolutions评级

证券之星
10 Jan

HC Wainwright&Co.:重申emergent BioSolutions(EBS.US)评级,由买入调整至买入评级,目标价由15.00美元调整至15.00美元。Emergent BioSolutions(EBS.US)公司简介:Emergent BioSolutions Inc向政府和医疗保健提供者提供公共卫生产品。该公司经营三个不同的部门,即商业部门、产品部门和服务部门。其主要收入来自...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10